Historical perspectives on the discovery and elucidation of autoantibodies to centromere proteins (CENP) and the emerging importance of antibodies to CENP-F

Autoimmunity Reviews

Volumn 10, Issue 4, 2011, Pages 194-200

  Fritzler, Marvin J ^a   Rattner, Jerome B ^a   Luft, LeeAnne M ^a   Edworthy, Steven M ^a   Casiano, Carlos A ^b   Peebles, Carol ^c   Mahler, Michael ^c  

^a UNIVERSITY OF CALGARY   (Canada)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INOVA DIAGNOSTICS INC   (United States)

Author keywords

Autoantibodies; Biomarkers; Cancer; CENP; CENP F; Centromere

Indexed keywords

AUTOANTIBODY; BINDING PROTEIN; BIOLOGICAL MARKER; CENTROMERE PROTEIN A; CENTROMERE PROTEIN B; CENTROMERE PROTEIN C; CENTROMERE PROTEIN D; CENTROMERE PROTEIN E; CENTROMERE PROTEIN F; CENTROMERE PROTEIN H; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; AUTOIMMUNITY; BREAST CANCER; HUMAN; LUNG CANCER; NONHUMAN; REVIEW; SYSTEMIC SCLEROSIS; TUMOR IMMUNITY;

ALLERGY AND IMMUNOLOGY; AUTOANTIBODIES; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CHROMOSOMAL PROTEINS, NON-HISTONE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MICROFILAMENT PROTEINS; NEOPLASMS;

EID: 79951854792     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2010.09.025     Document Type: Review

References (41)

1. Nakamura R.M., Peebles C.L., Molden C.P., Tan E.M. Advances in laboratory tests for autoantibodies to nuclear antigens in systemic rheumatic diseases. Lab Med 1984, 15:190-198.
2. Fritzler M.J., Kinsella T.D. The CREST syndrome: a distinct serologic entity with anticentromere antibodies. Am J Med 1980, 69:520-526.
3. Moroi Y., Peebles C.L., Fritzler M.J., Steigerwald J., Tan E.M. Autoantibody to centromere (kinetochore) in scleroderma sera. Proc Natl Acad Sci USA 1980, 77:1627-1631.
4. Tan E.M., Rodnan G.P., Garcia I., Moroi Y., Fritzler M.J., Peebles C. Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome. Arthritis Rheum 1980, 23:617-625.
5. Mahler M., Fritzler M.J. Epitope specificity and significance in systemic autoimmune diseases. Ann NY Acad Sci 2010, 1183:267-287. Review.
6. Earnshaw W.C., Machlin P.S., Bordwell B.J., Rothfield N.F., Cleveland D.W. Analysis of anticentromere autoantibodies using cloned autoantigen CENP-B. Proc Natl Acad Sci USA 1987, 84:4979-4983.
7. Mahler M., Maes L., Blockmans D., Westhovens R., Bossuyt X., Riemekasten G.S., et al. Clinical and serological evaluation of a novel CENP-A peptide based ELISA. Arthritis Res Ther 2010, 12:R99.
8. Mahler M., Mierau R., Genth E., Blüthner M. Development of a CENP-A/CENP-B-specific immune response in a patient with systemic sclerosis. Arthritis Rheum 2002, 46:1866-1872.
9. Akbarali Y., Matousek-Ronck J., Hunt L., Staudt L., Reichlin M., Guthridge J.M., et al. Fine specificity mapping of autoantigens targeted by anti-centromere autoantibodies. J Autoimmun 2006, 27:272-280.
10. Burlingame R.W., Rubin R.L. Anti-histone autoantibodies recognize centromeric heterochromatin in metaphase chromosomes and hidden epitopes in interphase cells. Hum Antibodies Hybridomas 1992, 3:40-47.
11. Sugimoto K., Kuriyama K., Himeno M., Muro Y. Epitope mapping of human centromere autoantigen centromere protein C (CENP-C); heterogeneity of anti-CENP-C response in rheumatic diseases. J Rheumatol 1998, 25:474-481.
12. Hayashi Y., Muro Y., Kuriyama K., Tomita Y., Sugimoto K. Differences in specificities of anti-centromere sera for the monomeric and dimeric C-terminal peptides of human centoromere protein C. Int Immunol 2000, 12:1431-1437.
13. Fritzler M.J., Valencia D.W., McCarty G.A. Speckled pattern antinuclear antibodies resembling anticentromere antibodies. Arthritis Rheum 1984, 27:92-96.
14. Casiano C.A., Landberg G., Ochs R.L., Tan E.M. Autoantibodies to a novel cell cycle-regulated protein which accumulates in the nuclear matrix during S phase and localizes to kinetochores and spindle midzone during mitosis. J Cell Sci 1993, 106:1045-1056.
15. Rattner J.B., Rao A., Fritzler M.J., Valencia D.W., Yen T.J. CENP-F is a ca 400kDa kinetochore protein that exhibits a cell-cycle dependent localization. Cell Motil Cytoskeleton 1993, 26:214-226.
16. Casiano C.A., Humbel R.L., Peebles C., Covini G., Tan E.M. Autoimmunity to the cell cycle-dependent centromere protein p330d/CENP-F in disorders associated with cell proliferation. J Autoimmun 1995, 85:75-86.
17. Rattner J.B., Rees J., Whitehead C.M., Casiano C.A., Tan E.M., Humbel R.L., et al. High frequency of neoplasia in patients with autoantibodies to centromere protein CENP-F. Clin Invest Med 1997, 20:308-319.
18. Landberg G., Erlanson M., Roos G., Tan E.M., Casiano C.A. Nuclear autoantigen p330d/CENP-F: a marker for cell proliferation in human malignancies. Cytometry 1996, 25:90-98.
19. Bencimon C., Salles G., Moreira A., Guyomard S., Coiffier B., Bienvenu J., et al. Prevalence of anticentromere F protein autoantibodies in 347 patients with non-Hodgkin's lymphoma. Ann NY Acad Sci 2005, 1050:319-326.
20. O'Brien S.L., Fagan A., Fox E.J., Millikan R.C., Culhane A.C., Brennan D.J., et al. CENP-F expression is associated with poor prognosis and chromosomal instability in patients with primary breast cancer. Int J Cancer 2007, 120:1434-1443.
21. Kingwell B., Rattner J.B. Mammalian centromere/kinetochore composition. A 50kDa antigen is present in the mammalian centromere/kinetochore. Chromosoma 1987, 95:403-407.
22. Ford A.L., Kurien B.T., Harley J.B., Scofield R.H. Anti-centromere autoantibody in a patient evolving from a lupus/Sjögren's overlap to the CREST variant of scleroderma. J Rheumatol 1998, 25:1419-1424.
23. Yen T.J., Compton D.A., Wise D., Zinkowski R.P., Brinkley B.R., Earnshaw W.C., et al. CENP-E, a novel human centromere-associated protein required for progression from metaphase to anaphase. EMBO J 1991, 10:1245-1254.
24. Rattner J.B., Rees J., Arnett F.C., Reveille J.D., Goldstein R., Fritzler M.J. The centromere kinesin-like protein, CENP-E an autoantigen in systemic sclerosis. Arthritis Rheum 1996, 39:1355-1361.
25. Sugata N., Munekata E., Todokoro K. Characterization of a novel kinetochore protein, CENP-H. J Biol Chem 1999, 274:27343-27346.
26. Henderson M.C., Shaw Y.L., Wang H., Han H., Hurley L.H., Flynn G., et al. UA62784, a novel inhibitor of centromere protein E kinesin-like protein. Mol Cancer Ther 2009, 8:36-44.
27. Schafer-Hales K., Iaconelli J., Snyder J.P., Prussia A., Nettles J.H., El-Naggar A., et al. Farnesyl transferase inhibitors impair chromosomal maintenance in cell lines and human tumors by compromising CENP-E and CENP-F function. Mol Cancer Ther 2007, 6:1317-1328.
28. Hsu T.C., Chang C.H., Lin M.C., Liu S.T., Yen T.J., Tsay G.J. Anti-CENP-H antibodies in patients with Sjogren's syndrome. Rheumatol Int 2006, 26:298-303.
29. Saito A., Muro Y., Sugiura K., Ikeno M., Yoda K., Tomita Y. CENP-O, a protein localized at the centromere throughout the cell cycle, is a novel target antigen in systemic sclerosis. J Rheumatol 2009, 36:781-786.
30. Arbuckle M.R., McClain M.T., Rubertone M.V., Scofield R.H., Dennis G.J., James J.A., et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003, 349:1526-1533.
31. Koenig M., Dieudé M., Senécal J.L. Predictive value of antinuclear autoantibodies: the lessons of the systemic sclerosis autoantibodies. Autoimmun Rev 2008, 7:588-593. Review.
32. Gelber A.C., Pillemer S.R., Baum B.J., Wigley F.M., Hummers L.K., Morris S., et al. Distinct recognition of antibodies to centromere proteins in primary Sjogren's syndrome compared with limited scleroderma. Ann Rheum Dis 2006, 65:1028-1032.
33. Abu-Shakra M., Buskila D., Ehrenfeld M., Conrad K., Shoenfeld Y. Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies. Ann Rheum Dis 2001, 60:433-440.
34. Szekanecz E., András C., Sándor Z., Antal-Szalmás P., Szántó J., Tamási L., et al. Malignancies and soluble tumor antigens in rheumatic diseases. Autoimmun Rev 2006, 6:42-47.
35. Atalay C., Dogan L., Atalay G. Anti-CENP-B antibodies are associated with prolonged survival in breast cancer. Future Oncol 2010, 6:471-477.
36. Atalay C., Atalay G., Yilmaz K.B., Altinok M. The role of anti-CENP-B and anti-SS-B antibodies in breast cancer. Neoplasma 2005, 52:32-35.
37. Shah A.A., Rosen A., Hummers L., Wigley F., Casciola-Rosen L. Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I/III antibodies. Arthritis Rheum 2010, 62:2787-2795.
38. Casiano C.A., Mediavilla-Varela M., Tan E.M. Tumor-associated antigen arrays for the serological diagnosis of cancer. Mol Cell Proteomics 2006, 5:1745-1759.
39. Farlow E.C., Patel K., Basu S., Lee B.S., Kim A.W., Coon J.S., et al. Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of non-small cell lung cancer. Clin Cancer Res 2010, 16:3452-3462.
40. Rom W.N., Goldberg J.D., Addrizzo-Harris D., Watson H.N., Khilkin M., Greenberg A.K., et al. Identification of an autoantibody panel to separate lung cancer from smokers and non-smokers. BMC Cancer 2010, 26(10):234.
41. Casal J.I., Barderas R. Identification of cancer autoantigens in serum: toward diagnostic/prognostic testing? Mol Diagn Ther 2010, 14:149-154.